Medicare AdvantageAdministrativeLow impact
[Ohio] Enhancing care for peri- and postmenopausal women: addressing recurrent UTIs with vaginal estrogen therapy
Anthem BCBS·OH · Urology, OB-GYN, Internal Medicine +1 more·Provider Bulletin
Effective date
Aug 1, 2026
We identified it
Aug 3, 2026
Summary
Anthem Blue Cross and Blue Shield (Ohio) is promoting vaginal estrogen therapy as an evidence-based treatment option for peri- and postmenopausal women with recurrent UTIs, aligned with American Urological Association guidelines. This is an educational bulletin encouraging provider awareness and patient counseling; no new billing codes, coverage restrictions, or prior authorization requirements are introduced.
Action Required
No billing system changes required. Clinical staff and providers should review the educational resources provided (AUA guidelines, ACOG resources) to familiarize themselves with vaginal estrogen therapy as a treatment option for eligible patients. Providers may optionally incorporate patient education materials into counseling workflows when discussing recurrent UTI management with perimenopausal and postmenopausal women. This is informational guidance only and does not alter existing billing, coding, or authorization processes.